LeMaitre Vascular

LeMaitre Vascular

A provider of devices, implants and services for the treatment of peripheral vascular disease.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*
N/A

$150m

Post IPO Convertible
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth19 %5 %20 %14 %12 %9 %10 %
EBITDA0000000000000000000000000000
% EBITDA margin24 %19 %26 %30 %28 %29 %31 %
Profit0000000000000000000000000000
% profit margin17 %13 %16 %20 %20 %21 %21 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue8 %8 %9 %7 %---

Source: Company filings or news article, Equity research estimates

More about LeMaitre Vascular
Made with AI
Edit

LeMaitre is a global provider of innovative medical devices designed specifically for vascular surgeons. The company operates in the healthcare sector, focusing on the treatment of peripheral vascular disease. LeMaitre's core product, the LeMaitre Valvulotome, has significantly improved the treatment of lower extremity arterial disease by allowing surgeons to cut valves in peripheral veins without the need for direct vision. This innovation has led to the saving of 180,000 legs over the past decade.

LeMaitre serves a diverse range of clients, including hospitals, clinics, and specialized vascular surgery centers across 90 countries. The company's business model revolves around the research, development, and sale of high-quality vascular devices. Revenue is generated through the direct sale of these devices to healthcare providers and through distribution agreements in various regions.

The company has expanded its product portfolio to include aortic polyester vascular grafts, vascular allografts, occlusion catheters, AV access systems, collagen vascular grafts, and more. This diverse range of products ensures that LeMaitre can meet various needs within the vascular surgery field.

LeMaitre's commitment to innovation and quality has established it as a trusted name among vascular surgeons worldwide. The company's ongoing research and development efforts aim to further enhance the effectiveness and efficiency of vascular treatments.

Keywords: vascular surgery, medical devices, peripheral vascular disease, LeMaitre Valvulotome, healthcare innovation, aortic grafts, occlusion catheters, AV access, global provider, vascular allografts.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by LeMaitre Vascular

Edit
Inavein
ACQUISITION by LeMaitre Vascular Aug 2013
Vascular Architects
ACQUISITION by LeMaitre Vascular Sep 2007
Restore Flow Allografts
ACQUISITION by LeMaitre Vascular Nov 2016
Prompt Serve
ACQUISITION by LeMaitre Vascular Mar 2023